A cross-sectional survey of anaesthesiologists in Singapore's restructured hospitals was conducted to explore strategies employed to obtain a bloodless surgical field during endoscopic sinus surgery.
INTRODUCTION
Endoscopic sinus surgery (ESS) is universally performed for sinus pathology 1, 2 . The frequent problem encountered during this surgery is bleeding, which may impede endoscopic vision thereby resulting in perioperative complications 1 . Various strategies have been employed to reduce the intraoperative bleeding so as to provide bloodless 'clean' surgical working conditions. These include use of topical vasoconstrictors, alpha-2 adrenergic agonists, alpha and beta adrenergic blockers, magnesium sulphate, steroids and choice of mode of ventilator and maintenance of carbon dioxide pressures 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Total intravenous anaesthesia with propofol and remifentanil has been shown to be superior to inhalational anaesthetic for providing optimal 'clean' surgical working conditions 1, [14] [15] [16] [17] [18] [19] [20] .
It has been hypothesised that reduction of cardiac output by reducing blood pressure and heart rate may minimise the surgical bleeding 1, 15, 18 . Therefore, the choice of anaesthetic agents plays a major role through their hypotensive and vasodilatory properties. However, each hypotensive technique has its own disadvantages, including reflex tachycardia, rebound hypertension, tachyphylaxis, myocardial depression and delayed emergence from anaesthesia 1, 12, 15, 17 . Reduction of cardiac output also carries the risk of ischaemic organ injury and associated mortality 1, 4, 17 .
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MATERIALS AND METHODS
Institutional review board approval from Singapore General Hospital was obtained for this survey. All practicing anaesthesiologists in public institutions in Singapore were invited to answer a questionnaire survey comprising 14 questions ( Fig. 1) . A point of contact per institution was appointed to assist in distribution and collection of the questionnaire forms. The questionnaire was administered from June 2012 to February 2013. The point of contact ensured that there was only one So far, there is no standard published guideline and the quantification of the benefit of each of these strategies is difficult to ascertain. The clinical practice appears to be mixed and it is unclear whether the choice of anaesthetic technique is guided by other factors such as cost.
We conducted a cross-sectional questionnaire survey among the anaesthesiologists in Singapore's public institutions to find out the strategies used to obtain a bloodless surgical field in their clinical practice. This information would help us understand the existing practice and possibly address areas where we could improve based on 1. Years since achieving qualification as associate consultant anaesthesist a) Less than 5 years b) 5-10 years c) 10 years and above 
RESULTS
A total of 114 anaesthesiologists completed the survey, from a potential pool of approximately 190 anaesthesiologists of Associate Consultant grade or higher in the restructured hospitals, giving a response rate of 60%. Tables 1 and 2 show the respondents' characteristics.
Airway management
With regard to airway management for ESS, an overwhelming majority (96.5%) chose to secure the airway with tracheal intubation, with the rest choosing supraglottic airway devices. 
Controlled hypotension

Total intravenous anaesthesia (TIVA)
Ninety-three point nine per cent of respondents were aware of the Schnider and Marsh pharmacologic models for target-controlled infusion (TCI) of propofol.
Limiting factors in using TIVA for ESS were explored. The major reasons cited were practical reasons (58.8%), which included the inconvenience of setting up and having extra infusion lines, and cost implications and availability (33.3%). Other reasons cited were the lack of knowledge of TIVA (3.5%) and a belief that TIVA is inferior to volatile anaesthetics for ESS (3.5%).
Drug choices for ESS and controlled hypotension
The narcotics most commonly used by the respondents in ESS were morphine (59.6%) and fentanyl (54.4%). Forty-four point seven percent of respondents used remifentanil. Alfentanil (0.9%) and oxycodone (0.9%) were the least commonly used. Table 3 details the opioid combinations used by the respondents for ESS.
If TIVA with propofol was employed, 86.0% of respondents would use remifentanil either alone or in combination with other opioids. This is followed by morphine (36.0%), fentanyl (24.6%), alfentanil (0.9%) and oxycodone (0.9%). One respondent indicated no opioid usage in this context. Table 4 illustrates the narcotics combinations chosen in conjunction with TIVA.
If drugs were required to control blood pressure, beta-blockers (66.7%) was most commonly used, with 50% of respondents favouring it as first line. Respondents also chose vasodilators (21.9%), dexmedetomidine (7.0%), clonidine (3.5%), magnesium (3.5%), calcium channel blockers (2.6%) and ACE inhibitors (0.9%) to help control blood pressure. Nine point six percent of respondents would not use any additional drugs for blood pressure control. Twenty-eight respondents indicated they would use drugs other than those listed. Of these, 9 would increase analgesia or depth of anaesthesia. Labetalol (11 respondents), hydralazine (2) and phentolamine (1) were specifically mentioned. Table 5 shows the respondents' drug choices in blood pressure control, as well as their first line of choices.
DISCUSSION
Controlled hypotension is defined as a fall in systolic blood pressure (SBP) to 80-90 mm Hg, or mean arterial pressure (MAP) to 50-65 mm Hg in patients without hypertension, or a fall of 30% of MAP in patients with hypertension 3, 4 . While it has been shown to reduce blood loss and improve surgical conditions in ESS 1,3,12,17,21 , it is not without risks. Mortality associated with ischaemic organ injury from controlled hypotension is estimated to be 0.06% 3, 4, 8, 17 . Furthermore, Ha et al. studied 32 patients undergoing hypotensive anaesthesia for ESS 21 and found that while reducing MAP improved bleeding scores, there was also a strong association with reduction of middle cerebral artery blood flow velocity (Vmca) as measured by transcranial Doppler ultrasonography. Ha's study suggests that based on Vmca flows, reducing MAP below 60 mm Hg may increase cerebral ischaemia risk.
Many studies reported good surgical conditions with moderate hypotension, defined as MAP of 60-70 mm Hg [5] [6] [7] [8] 11, 15, 17 . It is likely that nearly twothirds of respondents routinely choose not to actively employ controlled hypotension since this MAP target is often achieved under the effects of general anaesthesia, coupled with an intravascularly depleted fasted patient and a slight reverse Trendelenburg position.
Blood pressure targets in controlled hypotension should always be tailored to the individual patient's co-morbidities 3, 4 . Given that the questionnaire lacks an individualised clinical context, it is unsurprising that nearly half of the respondents aimed for MAP of 20-30% below baseline. It could also explain 6 non-responses and 10 respondents who did not specify their blood pressure targets.
Since MAP is a product of systemic vascular resistance (SVR) and cardiac output (CO), a reduction in arterial pressure can be attained by reductions in SVR, CO or both 1, 4 . SVR reduction with vasodilating agents require profound hypotension (MAP <50 mm Hg) to improve surgical conditions 1, 8, 22 . Moreover, vasodilation associated with hypotension may exacerbate bleeding and surgical conditions 1, 8, 22 . In comparison, hypotension produced by CO reduction due to bradycardia achieved better surgical conditions at MAP 60-70 mm Hg 1, 5, 8, 22 .
It is worth noting that 31.6% target a heart rate of less than 70 per minute, with 11.4% targeting a heart rate of 50 to 60 per minute. More than half of the respondents have no heart rate targets. Possible reasons include attainment of good surgical conditions through other techniques without a need for heart rate targets, and a lack of awareness.
Anaesthesia techniques and TIVA Several reviews and meta-analyses comparing intravenous and volatile anaesthesia for ESS have been published 1, 14, 18, 19, 23 . While there was little or no Proceedings of Singapore Healthcare  Volume 23  Number 4  2014 significant difference in blood loss reported, TIVA with propofol was found to provide better surgical conditions. Though only 21.1% of respondents thought TIVA was the best anaesthetic technique for ESS, it is worth noting that the reviews found few studies with sound methodology. This prevents the development of any definite recommendations currently and more high-quality studies are required 20, 23, 24 .
It is interesting that while 21.1% thought TIVA was the best anaesthetic technique for ESS, TIVA was the anaesthetic technique of choice of only 10.5% of respondents. This indicates non-clinical factors such as practical, logistical and financial issues influencing the decision to use TIVA. The choice of anaesthetic technique did not appear to be influenced by institutional practice and the vast majority of respondents indicate sufficient knowledge to employ TIVA comfortably.
More than 90% of respondents felt that practical reasons such as the inconvenience of setting up and having extra infusion lines, along with costs and availability of TIVA hindered them from using TIVA. As 40.4% routinely use BIS for TIVA, it implies that a significant proportion of respondents would have to contend with yet another implement.
A limitation of this questionnaire is the inability to further delineate the practical, logistical and financial factors preventing TIVA usage. It may be worthwhile exploring these reasons as some hurdles may be readily eradicated, so that patients are not denied TIVA when indicated.
Remifentanil
Remifentanil is associated with improved operative conditions in ESS 1,3,6,15,18,24 . The likely mechanism relates to its effects on bradycardia, thereby reducing cardiac output and arterial blood pressure 1, 3, 4 . Remifentanil has been shown to be as effective as sodium nitroprusside (SNP) and esmolol in achieving controlled hypotension in tympanoplasty 1, 18 .
Forty-four point seven per cent of respondents use remifentanil for ESS. Among the 40 respondents who actively employed controlled hypotension, 20 (or 50%) used remifentanil. This contrasts with a 41.9% remifentanil usage among respondents who did not actively employ controlled hypotension in ESS. There appears to be a propensity to use remifentanil when controlled hypotension is intended. However, remifentanil usage may be hindered by similar factors that plague TIVA use as outlined above. This is seen by a near two-fold increase to 86.0% in remifentanil use if TIVA was being employed, suggesting that once a case has been set up for intravenous infusions, it is less cumbersome practically and logistically to add an additional infusion line.
Anti-hypertensive agents
The questionnaire attempted to elucidate the types and preference of anti-hypertensive agents respondents use to lower blood pressure in controlled hypotension in a generalised context. In reality, the choice of anti-hypertensive agent used, if at all, depends largely on the cause of the elevated blood pressure as well as other haemodynamic parameters like heart rate. It is therefore possible that nine respondents felt unable to rank their choices of anti-hypertensive agents, and a further five did not specify what "other" drugs they would use.
Beta blockers were the overwhelming choice among respondents. While there is evidence that beta-1 adrenoreceptor blockade is effective in minimising blood loss and optimising surgical conditions in ESS 1,3-5,22,25 , favourable practical and logistical factors may also account for its wide-spread use. For example, labetalol and esmolol are readily available in most anaesthetic drug trolleys and do not require further dilution or preparation (although labetalol is a mixed alpha-and beta-adrenoreceptor blocker albeit with a more pronounced beta-blocking effect, it is possible that some respondents classified it as a beta-blocker for the purposes of answering the questionnaire since it was impractical to list all classes of antihypertensives). However, this is speculative since the questionnaire could not differentiate the type, timing and route of betablockers administered.
It would be interesting to further investigate local practices in beta-blocker administration. While intra-operative esmolol has been established as an agent that can lower heart rate and blood pressure, and improve surgical conditions 1, 3, 4, 22 , there are two studies which explored pre-operative oral beta-blockers for ESS and found good efficacy in improving operative conditions 5, 25 . However, as expected from drug elimination, the studies Proceedings of Singapore Healthcare  Volume 23  Number 4  2014 also showed better operative conditions earlier compared to the end of surgery 5 .
One should observe caution when administering beta-blockers in the context of hypertension induced by topical phenylephrine or submucosally injected adrenaline as there are case reports and series of resulting cardiogenic shock 26 . The proposed pathophysiology is an increase in alphareceptor stimulation from systemically absorbed topical vasoconstrictor with consequent rise in SVR. Compensatory inotropic and chronotropic mechanisms, to prevent flooding of pulmonary vasculature, are blunted by the administration of beta-blockers. A vicious circle ensues with ongoing, unopposed alpha stimulation 26 .
Alpha-2 adrenergic agonists, such as clonidine given pre-operatively or dexmedetomidine as an infusion intra-operatively, have been shown to improve surgical conditions and reduce blood loss in ESS 1, 3, 11, 13, 15 . The mechanism by which it achieves this is a reduction in cardiac output due to alpha-2 adrenergic bradycardic and sympatholytic effects, as well as peripheral vasoconstriction.
A few studies on dexmedetomidine in ESS demonstrate that besides being safe and effective in controlling blood pressure, it also provides good surgical conditions, and has the added advantages of analgesic and anaesthesia-sparing effects when compared to esmolol or remifentanil 11, 13, 15 . However, dexmedetomidine results in comparatively longer postoperative recovery times 13, 15 , and together with the logistics of setting-up an infusion, may deter respondents from more frequent usage. Other possible reasons for its low usage in controlled hypotension could include costs, availability and lack of familiarity or knowledge.
Oral clonidine pre-medication was shown in a few studies to improve surgical conditions 1, 3, 27 . Intravenous administration has not been studied, although it may be more successfully used as an oral pre-medication because of its sustained and unpredictable effects 3 . The questionnaire did not elicit the timing or route of administration of clonidine and it will be interesting to know if the local practice differs from the published study protocols.
Magnesium sulphate is a non-competitive antagonist of N-methyl-D-aspartate (NMDA) receptors 6, 12 . It therefore has anti-nociceptive effects, but it is its effects on the activation of cell membrane Ca ATPase, Na-K ATPase and L-type calcium channels, which reduces the outflow of calcium ions from the sarcoplasmic reticulum, that contributes to its vasodilatory effects 12 . Furthermore, magnesium sulphate causes vasodilation by increasing prostacyclin synthesis and decreasing angiotensin converting enzyme activity, and depresses the myocardium in a small, dose-dependent manner 12 .
Magnesium sulphate infusion for controlled hypotension is similar to dexmedetomidine in that both reduce analgesic requirements and lower heart rate and blood pressure, leading to improved surgical conditions, but also share the drawback of a longer post-operative recovery period 1, 6, 12 Only 8.8% of respondents favour vasodilators as the first choice drug to achieve controlled hypotension. Although the questionnaire could not differentiate the type of vasodilators used, they share a similar mechanism in decreasing arterial pressure by decreasing SVR. While the use of vasodilators will achieve the desired blood pressure, and in certain clinical contexts would be appropriate, its role in improving surgical conditions in ESS is limited. Peripheral vasodilation causes baroreceptorinduced reflex tachycardia and increased myocardial contractility which serve to maintain cardiac output 3 . This could explain why SNP requires profound hypotension to achieve surgical conditions attained by esmolol and remifentanil at moderate hypotension 1, 3, 5, 8, 18, 22 . Furthermore, SNP has many disadvantages including tachyphylaxis, rebound hypertension, myocardial ischaemia, increased intrapulmonary shunting, platelet dysfunction and cyanide toxicity 3, 4 . A study by Degoute et al. comparing SNP, remifentanil and esmolol for controlled hypotension during tympanoplasty showed a significant decrease in arterial pH in the SNP group 18 . The mean pH in this group was 7.28 taken 20 minutes after surgery, in the recovery. In comparison, the remifentanil and esmolol groups did not display acidosis at any time from the start of surgery through to recovery. Nitroglycerin, although possessing a better side effect profile than SNP, is not as effective at inducing hypotension, especially in younger patients 3, 4 . Hydralazine, which acts directly on vascular smooth muscles of arterioles and resistance vessels, may be a useful adjunct in blood pressure control. However, reflex tachycardia accompanies hypotension and it may not be readily titratable as its onset of action could take up to 20 minutes 4 .
Two point six per cent of respondents indicated that they would use calcium channel blockers for controlled hypotension, although it is unknown which specific agents they would have used. No calcium channel blocker has been studied in ESS. However, both nicardipine infusion and diltiazem as an adjunct has been successfully used to reduce blood loss in spinal surgery 3 . A downside of nicardipine is its relatively longer half-life and excessive decreases in blood pressure may not be quickly reversed 3, 4 .
Angiotensin-converting-enzyme inhibitors have been confined to being adjuncts in controlled hypotension due to their long duration of action, long delay to onset of action and elimination, conferring an unpredictable effect 3 . It is thus not surprising that only 0.9% of respondents chose to use it in controlled hypotension.
Airway devices
A study by Atef et al. 28 comparing the laryngeal mask airway (LMA) with endotracheal tube (ETT) for ESS found better surgical condition in the first 15 minutes and reduced blood loss. This could be explained by the lower sympathetic stimulation associated with LMA insertion as compared to tracheal intubation. After 15 minutes, the ETT group had comparable surgical conditions but required higher remifentanil doses to achieve blood pressure targets.
The LMA has been shown to provide smoother emergence from general anaesthesia when compared to ETT 1 . This is advantageous since coughing and straining during emergence increases venous engorgement and bleeding at the surgical site. However the LMA does not protect the airway against regurgitation, and high inspiratory pressures can cause gastric insufflation. Although Webster et al. 29 showed similar airway contamination rates between LMA and ETT with fibre-optic bronchoscopy at the end of ESS, contamination of the airways is still a major concern. This could explain why the overwhelming majority of respondents chose ETT for ESS. It is worth noting that virtually all LMA studies exclude patients with gastro-oesophageal reflux and obesity 1 .
Surgeons and institutional practice can also influence airway management choices. It is noteworthy that the 4 respondents who preferred to use LMA for ESS were from the same institution. 
Limitations
This study has several limitations. Firstly, the survey was open only to specialist anaesthesiologists in public institutions. A survey of private anaesthesiologists may yield different results as the financial, practical and logistical landscape could be different from public institutions.
Secondly, due to some logistical challenges, we were unable to survey specialists from one particular institution; this could have yielded up to 15 more responses, enriched the data and enabled us to explore any institutional differences. Despite a fair response rate of 60%, we cannot exclude response bias.
Thirdly, a survey with a questionnaire may introduce recall bias. However, this survey explored the practice preferences of anaesthesiologists for ESS in a generalised setting rather than actual drugs and haemodynamic targets used for each patient. While an audit of all ESS cases, accounting for each individual patient's clinical context, would yield a more accurate reflection of actual practice, a questionnaire was felt to be sufficient in finding out their strategies used to obtain a bloodless surgical field.
Due to the practicalities of keeping the questionnaire brief, we were unable to elicit specific drugs used, their administration routes and timing. In particular, for Question 12, including labetalol, hydralazine and increasing anaesthesia doses as separate choices may have improved our analysis since these are common means of controlling blood pressure intra-operatively. With regard to limiting factors in the use of TIVA, we were unable to document specifically the types of practical reasons for not using TIVA. Moreover, without a specific clinical context, it appears that respondents felt that some questions were an over-generalisation which resulted in poorer response rates for those questions. Despite this, the response rate consistently exceeded 92% for all the questions.
In conclusion, this survey identifies variations from current evidence in the anaesthetic management of ESS among anaesthesiologists in Singapore's public institutions who responded to this survey. Notably, nearly two-thirds of respondents routinely choose not to actively employ controlled hypotension in ESS. Reasons should be sought and these may include surgeon preferences, financial, logistical, cultural, and possibly educational factors. Capital investment, interdisciplinary dialogues and education are likely solutions to this. Perhaps a survey of local otorhinolaryngologists regarding surgical conditions and blood loss in ESS could allow anaesthesiologists to confidently eschew controlled hypotension in ESS as the risks of maintaining a MAP below 60 mm Hg may outweigh its benefits if satisfactory surgical conditions have been obtained. Finally, more well-designed studies are needed in certain areas with clinical equipoise, such as the efficacy of TIVA with propofol in improving surgical conditions in ESS.
